Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 5
2003 4
2004 5
2005 10
2006 7
2007 7
2008 6
2009 11
2010 10
2011 14
2012 14
2013 22
2014 20
2015 10
2016 7
2017 16
2018 14
2019 11
2020 13
2021 15
2022 10
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Results by year

Filters applied: . Clear all
Page 1
Demographics of sources of HIV-1 transmission in Zambia: a molecular epidemiology analysis in the HPTN 071 PopART study.
Hall M, Golubchik T, Bonsall D, Abeler-Dörner L, Limbada M, Kosloff B, Schaap A, de Cesare M, MacIntyre-Cockett G, Otecko N, Probert W, Ratmann O, Bulas Cruz A, Piwowar-Manning E, Burns DN, Cohen MS, Donnell DJ, Eshleman SH, Simwinga M, Fidler S, Hayes R, Ayles H, Fraser C; HPTN 071 (PopART) Phylogenetics protocol team; PANGEA consortium. Hall M, et al. Among authors: eshleman sh. Lancet Microbe. 2024 Jan;5(1):e62-e71. doi: 10.1016/S2666-5247(23)00220-3. Epub 2023 Dec 8. Lancet Microbe. 2024. PMID: 38081203 Free PMC article. Clinical Trial.
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial.
Landovitz RJ, Hanscom BS, Clement ME, Tran HV, Kallas EG, Magnus M, Sued O, Sanchez J, Scott H, Eron JJ, Del Rio C, Fields SD, Marzinke MA, Eshleman SH, Donnell D, Spinelli MA, Kofron RM, Berman R, Piwowar-Manning EM, Richardson PA, Sullivan PA, Lucas JP, Anderson PL, Hendrix CW, Adeyeye A, Rooney JF, Rinehart AR, Cohen MS, McCauley M, Grinsztejn B; HPTN 083 Study Team. Landovitz RJ, et al. Among authors: eshleman sh. Lancet HIV. 2023 Dec;10(12):e767-e778. doi: 10.1016/S2352-3018(23)00261-8. Epub 2023 Nov 9. Lancet HIV. 2023. PMID: 37952550 Free article. Clinical Trial.
Population-level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART).
Grant-McAuley W, Piwowar-Manning E, Clarke W, Breaud A, Zewdie KB, Moore A, Ayles HM, Kosloff B, Shanaube K, Bock P, Meehan SA, Maarman G, Fidler S, Hayes R, Donnell D, Eshleman SH; HPTN 071 (PopART) Study Team. Grant-McAuley W, et al. Among authors: eshleman sh. J Int AIDS Soc. 2023 Oct;26(10):e26179. doi: 10.1002/jia2.26179. J Int AIDS Soc. 2023. PMID: 37886843 Free PMC article. Clinical Trial.
Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial.
Marzinke MA, Hanscom B, Wang Z, Safren SA, Psaros C, Donnell D, Richardson PA, Sullivan P, Eshleman SH, Jennings A, Feliciano KG, Jalil E, Coutinho C, Cardozo N, Maia B, Khan T, Singh Y, Middelkoop K, Franks J, Valencia J, Sanchez N, Lucas J, Rooney JF, Rinehart AR, Ford S, Adeyeye A, Cohen MS, McCauley M, Landovitz RJ, Grinsztejn B; HPTN 083 study group. Marzinke MA, et al. Among authors: eshleman sh. Lancet HIV. 2023 Nov;10(11):e703-e712. doi: 10.1016/S2352-3018(23)00200-X. Epub 2023 Sep 29. Lancet HIV. 2023. PMID: 37783219 Clinical Trial.
Comprehensive profiling of pre-infection antibodies identifies HIV targets associated with viremic control and viral load.
Grant-McAuley W, Morgenlander W, Hudelson SE, Thakar M, Piwowar-Manning E, Clarke W, Breaud A, Blankson J, Wilson E, Ayles H, Bock P, Moore A, Kosloff B, Shanaube K, Meehan SA, van Deventer A, Fidler S, Hayes R, Ruczinski I, Kammers K, Laeyendecker O, Larman HB, Eshleman SH. Grant-McAuley W, et al. Among authors: eshleman sh. Front Immunol. 2023 Sep 6;14:1178520. doi: 10.3389/fimmu.2023.1178520. eCollection 2023. Front Immunol. 2023. PMID: 37744365 Free PMC article. Clinical Trial.
Recommendations on data sharing in HIV drug resistance research.
Inzaule SC, Siedner MJ, Little SJ, Avila-Rios S, Ayitewala A, Bosch RJ, Calvez V, Ceccherini-Silberstein F, Charpentier C, Descamps D, Eshleman SH, Fokam J, Frenkel LM, Gupta RK, Ioannidis JPA, Kaleebu P, Kantor R, Kassaye SG, Kosakovsky Pond SL, Kouamou V, Kouyos RD, Kuritzkes DR, Lessells R, Marcelin AG, Mbuagbaw L, Minalga B, Ndembi N, Neher RA, Paredes R, Pillay D, Raizes EG, Rhee SY, Richman DD, Ruxrungtham K, Sabeti PC, Schapiro JM, Sirivichayakul S, Steegen K, Sugiura W, van Zyl GU, Vandamme AM, Wensing AMJ, Wertheim JO, Gunthard HF, Jordan MR, Shafer RW. Inzaule SC, et al. Among authors: eshleman sh. PLoS Med. 2023 Sep 22;20(9):e1004293. doi: 10.1371/journal.pmed.1004293. eCollection 2023 Sep. PLoS Med. 2023. PMID: 37738247 Free PMC article.
Evaluating the impact of point-of-care HIV viral load assessment on linkage to care in Baltimore, MD: a randomized controlled trial.
Bayan MH, Smalls T, Boudreau A, Mirza AW, Pasco C, Demko ZO, Rothman RE, Hsieh YH, Eshleman SH, Mostafa HH, Gonzalez-Jimenez N, Chavez PR, Emerson B, Delaney KP, Daugherty D, MacGowan RJ, Manabe YC, Hamill MM. Bayan MH, et al. Among authors: eshleman sh. BMC Infect Dis. 2023 Sep 1;23(1):570. doi: 10.1186/s12879-023-08459-7. BMC Infect Dis. 2023. PMID: 37658305 Free PMC article. Clinical Trial.
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.
Marzinke MA, Fogel JM, Wang Z, Piwowar-Manning E, Kofron R, Moser A, Bhandari P, Gollings R, Bushman LR, Weng L, Halvas EK, Mellors J, Anderson PL, Persaud D, Hendrix CW, McCauley M, Rinehart AR, St Clair M, Ford SL, Rooney JF, Adeyeye A, Chariyalertsak S, Mayer K, Arduino RC, Cohen MS, Grinsztejn B, Hanscom B, Landovitz RJ, Eshleman SH. Marzinke MA, et al. Among authors: eshleman sh. Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0005323. doi: 10.1128/aac.00053-23. Epub 2023 Mar 30. Antimicrob Agents Chemother. 2023. PMID: 36995219 Free PMC article.
HTPN 078: an enhanced case management study to achieve viral suppression among viremic HIV-positive men who have sex with men in the United States.
Remien RH, Dacus JD, Farley JE, Hughes JP, Gamble T, Wang ZZ, Batey DS, Mayer KH, Del Rio C, Balán IC, Irvin R, Mitchell KM, Cummings V, Eshleman SH, Conserve DF, Knox J, Yu K, Beyrer C; HPTN 078 Study Team. Remien RH, et al. Among authors: eshleman sh. AIDS. 2023 Feb 1;37(2):217-231. doi: 10.1097/QAD.0000000000003411. Epub 2022 Oct 21. AIDS. 2023. PMID: 36541636 Free PMC article. Clinical Trial.
Antiretroviral Drug Detection in a Community-Randomized Trial of Universal HIV Testing and Treatment: HPTN 071 (PopART).
Fogel JM, Zewdie K, Clarke WA, Piwowar-Manning E, Breaud A, Moore A, Kosloff B, Shanaube K, van Zyl G, Scheepers M, Floyd S, Bock P, Ayles H, Fidler S, Hayes R, Donnell D, Eshleman SH; HPTN 071 (PopART) Study Team. Fogel JM, et al. Among authors: eshleman sh. Open Forum Infect Dis. 2022 Oct 31;9(11):ofac576. doi: 10.1093/ofid/ofac576. eCollection 2022 Nov. Open Forum Infect Dis. 2022. PMID: 36447611 Free PMC article.
227 results